Synthetic peptide vaccines | Zendy

Alexander Moysa | Zendy; Е. Ф. Колесанова | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Synthetic peptide vaccines

Author(s) -

Alexander Moysa,

Е. Ф. Колесанова

Publication year - 2011

Publication title -

biomeditsinskaya khimiya

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 0.192

H-Index - 15

eISSN - 2310-6972

pISSN - 2310-6905

DOI - 10.18097/pbmc20115701014

Subject(s) - malaria , infectious disease (medical specialty) , malaria vaccine , peptide , virology , biopharmaceutical , computational biology , proteomics , biology , immunology , medicine , plasmodium falciparum , disease , microbiology and biotechnology , gene , genetics , biochemistry , pathology

This review considers the stages of the development of synthetic peptide vaccines against infectious agents, novel approaches and technologies employed in this process, including bioinformatics, genomics, proteomics, large-scale peptide synthesis, high-throughput screening methods, the use of transgenic animals for modelling human infections. An important role for the development and selection of efficient adjuvants for peptide immunogens is noted. Examples of synthetic peptide vaccine developments against three infectious diseases (malaria, hepatitis C, and foot-and-mouth disease) are given.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research